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ABSTRACT 
 
 
The human ribosome is an RNA-protein complex responsible for protein synthesis in the 
cell.  Crystal structures of bacterial ribosomes solved to date depict no protein sidechains 
within the catalytic core, or peptidyl transferase center (PTC) [1].  This region of the 
human ribosome comprises approximately 230 highly conserved nucleotides.  Notably, 
several of the uridine bases clustered within the human PTC are post-transcriptionally 
modified to pseudouridines, as compared with bacterial analogues [2].  Pseudouridines 
are base-rotated uridines, linked to their sugar moieties through C5-C1' linkages, 
affording additional hydrogen-bond donor groups at the N1 position of their rings [3].  A 
connection was recently made between the absence of pseudouridines within the PTC and 
diseases such as dyskeratosis congenita, leukemia, and solid tumor cancers; however, the 
function of pseudouridine in the PTC is unknown [4].  PTC RNA constructs are being 
synthesized with and without wild-type pseudouridine modifications to assess possible 
structural and dynamic roles of these bases.  UV thermal denaturation and circular 
dichroism experiments are planned to identify key physical differences between the 
modified and unmodified PTC.  Small angle x-ray scattering studies will also be 
performed on the two models for low resolution conformational comparison.  Our goal is 
to make a significant contribution to the growing body of knowledge addressing the 
relationship between the absence of pseudouridines and malignancy. 
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CHAPTER ONE 
INTRODUCTION 
 
 The ribosome is a biomolecular complex composed of proteins and ribonucleic 
acids which serves as the translation center for the genetic material in the cell.  The 
ribosomal ribonucleic acid (rRNA) 28S is a highly structured molecule which contains 
the peptidyl transferase center, the catalytic core of the ribosome.   This chapter describes 
the nature of RNA structure in general and also the role of the 28S subunit responsible for 
catalyzing peptide bond formation.  The peptidyl transferase center is discussed in terms 
of the uridine modifications (pseudouridines) it contains.  Additionally, the medical 
impact of pseudouridine synthesis is outlined. 
 
RNA Structure 
 Ribonucleic acid (RNA) is a versatile molecule which can play many different 
roles in the cell due to its structural complexity.  RNA is a polymer of nucleotide subunits 
which each consist of a nitrogenous base attached to a five carbon ribose sugar and a 
phosphate group.  There are four different standard bases which RNA uses to fill its 
various functions; these are adenine (A), cytosine (C), guanine (G), and uracil (U) (figure 
1.1).   
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These bases can further be divided into two main groups, purines and 
pyrimidines.  Purines include adenine and guanine and can be distinguished from the 
other bases by their unique structure, a six-membered nitrogen containing ring fused to a 
5-membered nitrogen containing ring.  Pyrimidines include cytosine and uracil and are 
simply one six-membered nitrogen containing ring.   
 
 
Figure 1.1: RNA bases adenine (A), guanine (G), cytosine (C), and uracil (U) [5] 
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When the sugar ribose bonds to a purine, carbon 1 of the sugar attaches to 
nitrogen 9 of the base, but if the sugar bonds to a pyrimidine then carbon 1 of the sugar 
attaches to nitrogen 1 of the base.  In RNA the purine adenine always base pairs with the 
pyrimidine uracil through the formation of two hydrogen bonds.  Thus, the purine 
guanine always base pairs with the pyrimidine cytosine through the formation of three 
hydrogen bonds.  The sequence of the above base pairing ultimately determines the 
secondary structure of RNA since this structure is mostly determined by the placement of 
the hydrogen bonds that are formed.  As a result, there are a number of RNA secondary 
structures which can range from hairpin stem-loops, formed when RNA folds on itself, to 
junctions (figure 1.2).  The secondary structure of RNA is critical and can mean the 
difference between proper functioning of the molecule and malfunctioning.  Additionally, 
with technology today, the secondary structure of RNA can be predicted fairly accurately 
using computational biophysical methods. 
The tertiary structure of RNA is the molecule’s three-dimensional shape.  It is 
more stable and energetically favorable than other structures.  Tertiary structure is formed 
in the presence of 1) two helices, 2) two unpaired regions, or 3) one unpaired region and 
a double stranded helix [6].  As with the secondary structure, tertiary structure is largely 
determined by the arrangement of the nucleotides.  Conversely, it is difficult to predict 
the tertiary structure since it is heavily influenced by the environment in which it is 
synthesized. 
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Figure 1.2:  A few secondary structures of RNA: (a) Tetra loop, (b) π-turn, (c) Ω-turn, (d) 
S2 motif, (e) E-loop, (f) Kink turn [7] 
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Human Ribosome 28S 
Essentially, the ribosome is responsible for making all of the body’s proteins.  It is 
an enzyme which translates the messenger ribonucleic acid (mRNA) code into an amino 
acid chain which then folds into a protein.  This crucial step in the process of 
synthesizing proteins from genes would not be possible without the ribosome.  In 
eukaryotes the ribosome consists of a large (60S) subunit which in turn is comprised of 
smaller subunits, the 5S, 5.8S and 28S subunits along with large subunit proteins.  
Additionally, the ribosome has a small (40S) subunit composed of the 18S subunit along 
with small subunit proteins.  A graphical depiction of the prokaryotic 70S ribosome is 
seen in figure 1.3, as this ribosome is structurally quite similar to the eukaryotic version. 
 The small subunit contains the region where mRNA codons are read and matched 
to appropriate transfer RNA (tRNA) anticodons and is ultimately responsible for ensuring 
proper protein synthesis.  The large subunit is responsible for such tasks as catalyzing 
peptide bond formation and binding certain factors needed for initiation, the beginning of 
translation from RNA to amino acids, elongation, the addition of amino acids to the 
polypeptide chain, and termination, the release of the amino acid chain from the 
ribozyme complex.  The 28S subunit of the large ribosomal RNA subunit contains 
approximately 4700 nucleotides which are highly conserved throughout eukaryotes.  For 
example, in helix 69 of the large rRNA subunit 88% of the base pairs formed in the 
secondary structure are maintained [8].  This research will focus on the region of the 28S 
subunit that contains the Peptidyl Transferase Center (PTC). 
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Figure 1.3: 3D structure of 70S prokaryotic ribosome showing the 50S subunit in blue, 
purple, and cyan and the 30S subunit in yellow and light green.  The blue section of the 
50S subunit is the 23S ribosomal RNA while the green strands in the 30S subunit are the 
16S ribosomal RNA.  The blue, orange, and burnt orange molecules in the center are the 
tRNA at the A, P, and E sites respectively [9] 
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Peptidyl Transferase Center 
The Peptidyl Transferase Center is a region of RNA about 230 nucleotides long 
which catalyzes peptide bond formation.  This section of the ribosome is exceptionally 
tightly structured and as can be seen from the 3-dimensional crystal structure (figure 1.4).  
The ribosome is considered a ribozyme because there are no protein side-chains within 
the PTC and so this reaction is catalyzed entirely by RNA.  Forming peptide bonds is in 
essence how poly-peptide chains are synthesized; therefore the structure and content of 
the PTC are important for cell vitality.  Ten uridines within the PTC are post-
transcriptionally modified to pseudouridines; the role these bases play in determining the 
structure and maintaining the fidelity of the ribosome is the focal point of this research. 
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Figure 1.4: A) Primary and secondary structure of the PTC showing locations of 
pseudouridines. B) 3-dimensional crystal structure of the PTC with labeled helices [2] 
A) B) 
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Pseudouridines 
The RNA in Eukaryotes is made up of much more than the four standard bases 
adenine, cytosine, guanine, and uridine.  There are many modified bases which boost the 
catalytic ability of RNA as a ribozyme.  One of the most common base modifications is 
an isomerization of uridine to pseudouridine [10].  The pseudouridine is a base rotated 
version of uridine with the sugar moiety connected to the base via a Carbon (C1’- C5) 
instead of Nitrogen (C1’- N1) (figure 1.5).  This rotation allows the base to more freely 
participate in forming the structure of the RNA molecule.  
 
 
 
Figure 1.5: Conversion of uridine to pseudouridine.  Note the bond shift from the sugar 
ribose (R) to the pyrimidine ring.  Uridine has a carbon nitrogen bond while 
pseudouridine has a carbon carbon bond [3] 
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Research shows that as the complexity of an organism increases so does the 
number of pseudouridine residues present in the large subunit of its ribosomal RNA 
(rRNA).  For example, the large subunit of rRNA in eukaryotes is composed of anywhere 
from 0.9%-1.4% of pseudouridines compared to the large subunit of rRNA in bacteria 
with only 0.03%-0.4%.  This translates into 55 pseudouridines in the large subunit of 
human rRNA versus 10 pseudouridines in the large subunit of Escherichia coli rRNA 
[11].  Additionally, in humans 7.3% of uridines found in the large ribosomal subunit are 
converted to pseudouridines while only 1.5% of uridines found in the large subunit of 
rRNA in E. coli are subsequently converted into pseudouridines.  Looking closer 
researchers have found that not only do base modifications tend to occur in functionally 
important regions specifically the peptidyl transferase center, but they are also universally 
conserved providing certain advantages [12]. For example, in human 28S rRNA there are 
five highly conserved pseudouridines located in the Helix 69 hairpin structure (figure 1.6) 
[8]. 
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Figure 1.6:  Highly conserved Pseudouridines in helix 69 of Homo sapiens [8] 
 
 
Motivation for Research 
 Dyskeratosis congenita is a poorly understood genetic disorder that affects 
approximatly 1 in 1 million people and which, to date, has no cure [13].  First identified 
about one-hundred years ago it can be diagnosed through the presence of numerous side-
effects.  Classic symptoms include nail dystrophy, irregular skin color and oral 
leukoplakia, patches of white plaque that occur in the mouth (figure 1.7). Nail dystrophy 
is found in 90% of those diagnosed with dyskeratosis congenita and results in nail 
malformation due to the thinning and splitting of the nail as well as keratin deposites that 
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occur between the nail plate and nail bed causing the nail to be elevated.  Abnormal skin 
pigmentation is present in 90% of patients with skin color ranging from tan to gray and 
occurs in a mesh-like pattern.  Oral leukoplakia appears in 80% of Dyskeratosis 
congenita patients and tends to be located on the inside of the cheek, the tongue, or the 
oral part of the pharynx.  Another prevalent consequence of this disease is bone marrow 
failure which occurs in 85% of people diagnosed with this disease and ultimately causes 
80% of patient deaths [13].  There is an additional problem though; patients diagnosed 
with Dyskeratosis congenita have also been found to be especially susceptible to solid 
tumor cancers and leukemia [4].   
 
 
 
 
 
 
 
Figure 1.7: The three classic symptoms of Dyskeratosis Congenita: A) Nail Dystrophy, 
B) Abnormal Skin Pigmantation, and C) Oral Leukoplakia [13] 
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Dyskeratosis congenita has been linked to the mutation of several genes and 
proteins some of which are important in the synthesis of pseudouridines.  Some examples 
include DKC1, located on the X chromosome at position 28, and small nucleolar proteins 
NOP10, NHP2 and GAR1.  DKC1 is responsible for making the nucleolar protein 
dyskerin, a pseudouridine synthase that among other functions also assists with ribosomal 
RNA processing.  Additionally, dyskerin, NOP10, NHP2, and GAR1 are all an important 
part of a class of proteins called small nucleolar ribonucleoprotein particles (snoRNPs) 
which function in binding small nuclelolar RNAs (snoRNAs).  After binding, these 
proteins they assist with pseudouridylation in RNA.  Just to clarify, dyskerin is necessary 
for synthesizing pseudouridine while NOP10, NHP2, and GAR1 are required for 
pseudouridylation in pre-rRNA to occur [13].  
This research can lead to significant advances in the knowledge base concerning 
how and why this disease occurs.  Answers to questions such as; what do pseudouridines 
do in the ribosome? and How does the structure of the PTC in the ribosome change in the 
absence of pseudouridines? can lead to treatments in the future which will be able to 
correct these changes and replace the functionality of the missing pseudouridines.  
Knowing the problem is always the first step to finding a solution, and so it is with this 
lofty goal that our pseudouridine research is undertaken. 
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CHAPTER TWO 
PHYSICAL AND BIOCHEMICAL TOOLS 
 
 This research will be making use of many physical and biochemical tools to 
gather the various data needed for analysis of the samples in question.  These techniques 
are divided into biochemical ones used for synthesis of the sample and physical ones that 
will be used for data collection and structural characterization.  Polymerase chain 
reactions, DNA-splinted ligations, electrophoresis gel assays, and ultra violet 
spectrophotometry are the biochemical tools which will be used to synthesize the 
unmodified and wild-type RNA molecules.  Additionally, after synthesis is complete 
ultra violet spectrophotometry, circular dichroism, and small angle x-ray scattering will 
be used to gather the data necessary to physically compare these two molecules and draw 
distinct conclusions about the role that pseudouridine plays in the PTC’s structural 
conformation. 
 
Polymerase Chain Reaction 
 A polymerase chain reaction is a method used to amplify a specific DNA 
sequence by continually cycling through stages of denaturation, annealing, and 
elongation by quickly changing temperatures using a thermal cycler like the PCR Sprint 
Thermal Cycler (Thermo Electron Corporation).  The method works so well because each 
time a thermal cycle is completed the amount of product has doubled, thus giving an 
exponential return on the original DNA.  The process relies on a DNA polymerase 
enzyme such as Invitrogen’s Taq DNA polymerase (AccuPrime Taq DNA Polymerase 
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System) to extend primer DNA fragments which are complementary to part of the desired 
DNA oligo, the template.  For part of this research, the primers themselves will also serve 
as the template by containing overlapping bases.  In this way each primer will be 
extended to become a DNA strand containing both the bases complementary to the 
second primer and the original bases from itself. 
 
DNA Splinted Ligation 
The body has many natural ways to join strands of nucleic acids together 
including a method called ligation.  One use the body has for ligation is to seal ‘nicks’ in 
double stranded DNA.  This method uses a ligase enzyme to join together a strand of 
DNA which has been cleaved on one side of the double stranded helix.  This enzyme has 
another important use in the lab however; it can be tricked into joining together two 
single strands of RNA.  This method is referred to as DNA splinted ligation. 
DNA splinted ligation to join together RNA oligos is typically done with the 
enzyme T4 DNA Ligase.  In order to ‘trick’ the T4 Ligase into joining together RNA 
instead of DNA, a DNA template, which has a sequence complementary to that of the 
region of the RNA surrounding the ligation site, is attached to the both pieces of RNA, 
temporarily joining them together.  Then the T4 Ligase sees this double stranded complex 
and seals the ‘nick’ in the RNA by catalyzing the formation of a phosphodiester bond 
between the 5’ monophosphate of the donor RNA and the 3’ OH of the acceptor RNA 
[14]. After the process is done, the DNA template is removed and a single ligated piece 
of RNA is left. 
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Electrophoresis Gel Assays 
Electrophoresis gel assays are useful tools for visualizing the different nucleic 
acid fragments in a solution.  Polyacrylamide gels are made from acrylamide solution 
which has polymerized into a lattice of pores on the order of a nanometer in diameter.  
When a potential difference is placed between the two ends of the gel in a buffer, it 
serves as a medium for the nucleic acid fragments to migrate in since their phosphate 
backbone is negatively charged.  The result is a “lane” in which the fragments are 
separated based on size and conformation.  An RNA fragment which is small or folded 
will move farther down on a gel than a large or denatured one.  The nucleic acids are 
stained with dyes in order to visualize their progress down the lane; for denaturing gels a 
1X formamide dye (90% formamide, 1X TBE, 0.025% bromophenol blue, 0.025% 
xylene cyanol) is used to reduce the secondary and tertiary structures formed by the 
single-stranded nucleic acid, and for non-denaturing gels a 6X dye (10 mM Tris-HCl (pH 
7.6), 0.03% bromophenol blue, 0.03% xylene cyanol, 60% glycerol, 60 mM EDTA) is 
used.  When the dyes have run down to the desired position, the gel is removed from the 
apparatus and stained with ethidium bromide which intercalates between the bases and 
fluoresces in ultra violet (UV) light.  The gel is then removed from the ethidium bromide 
and de-stained in distilled water to remove excess ethidium bromide and reduce 
background noise.  Finally the gel is placed on a transilluminator (Fischer Scientific) 
which shines UV light through the gel so the ethidium bromide can be seen where it has 
intercalated in the nucleic acid. 
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Ultra-Violet Spectrophotometry 
Ultra Violet (UV) spectrophotometry is used to measure the absorbance of energy 
by a particular molecule or nucleic acid fragment.  RNA and DNA molecules are known 
to absorb light with a wavelength of 260nm in the UV range because they are composed 
of aromatic planar rings.  These rings act as chromophores which absorb energy that 
induces a transition dipole moment; therefore, when the formation of this transition 
dipole moment in inhibited by the alignment of dipoles that occurs when bases stack in a 
duplex, their absorbance goes down [15,16].  Thus this tool has two uses in this research: 
to measure the absorbance of the RNA molecules in their native form and to determine 
the molecule’s melting temperature and other thermodynamic properties with Van’t Hoff 
analysis.   
A UV-Visible Spectrophotometer (Varian, Cary 300Bio) actually measures the 
amount of light which is transmitted through a solution at varying wavelengths; using the 
intensity of light shown on a sample and the intensity transmitted through it, a 
transmittance percentage is determined, or transmissivity.  This transmissivity is then 
used to calculate the absorbance for a species at a given wavelength using the Beer-
Lambert law which states that T = e-αl and A = αl where A is the absorbance, α is the 
absorption coefficient, l is the path length of the light, and T = I/I0 (T is transmissivity, I 
is transmitted light intensity, I0 is incident light intensity).  This means that the 
transmissivity is logarithmically dependant on the absorbance, however when the 
transmitted light is given in ratio form, then the absorbance becomes easy to measure 
A = -ln(I/I0). 
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Circular Dichroism 
Circular Dichroism (CD) measures the difference between absorption of left and 
right circularly polarized light by a chiral substance.  Many biological molecules, 
including proteins and RNA, have chirality, or handedness.  The chirality of a molecule is 
dependent on the arrangement of its atoms; if a molecule cannot be superimposed on its 
mirror image then it is said to be chiral.  Therefore the secondary and tertiary structures 
of RNA play an important role in determining its chirality as they change the way the 
bases are aligned and positioned with respect to each other.  One way to distinguish a 
molecule from its enantiomer (chiral mirror image) is by the direction it rotates light 
passed through it, either to the right or left.  This chirality manifests itself when circularly 
polarized light is radiated onto a substance because light of the same chirality as the 
substance is absorbed differently than light of the opposite chirality.  The CD of a 
molecule is reported as molar ellipticity (θ [°]) vs wavelength (λ [nm]); the molar 
ellipticity can be found from the difference between the extinction coefficient for left and 
right circularly polarized light, or ∆ϵ = ϵ_L - ϵ_R, by the conversion factor 
θ = 3298.2∆(A/cl) where the Beer-Lambert law has also been used to convert absorbance 
to extinction coefficient (A = εcl).  Thus ∆ϵ can be measured for two molecules and their 
spectra compared to see how structurally different they are. 
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Small-Angle X-Ray Scattering 
Small-Angle X-Ray Scattering (SAXS) is a characterization method often 
employed to obtain low resolution structural data for biological macromolecules.  This 
technique involves detecting the intensity of monochromatic x-rays accelerated from a 
synchrotron and which have scattered at low angles from a sample (figure 2.1).  The x-
ray intensities can be used as a function of the scattering angle to calculate global 
structure and conformation properties of the sample molecule.  The data obtained comes 
from inhomogeneities of the electron density in the sample which are modeled into 
structural landmarks.  There are several distinct advantages to using SAXS when all that 
is needed is global conformational data, including the ability to characterize large 
samples which would not be ideally suited to nuclear magnetic resonance studies and the 
capacity to use samples in solution form as opposed to crystallized form. 
 
Figure 2.1:  Schematic of SAXS process and sample data spectrum [17] 
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CHAPTER THREE 
SYNTHESIS OF UNMODIFIED PTC RNA 
 
 The first step toward obtaining data comparing the structural properties of PTC 
RNA with and without pseudouridines is to obtain the PTC constructs without 
pseudouridines, or unmodified PTC RNA. There are many challenges to face when 
producing custom segments of nucleic acids, especially when they are longer than a few 
nucleotides.  The most efficient and cost-effective method for synthesizing these RNA 
oligos is to transcribe the RNA using in vitro techniques.  In vivo methods are available 
such as transcribing RNA from a vector plasmid; however it is time consuming to grow 
the plasmids in cell cultures and requires special laboratory equipment.  The in vitro 
method involves first using PCR to amplify small DNA primers and then transcribing 
RNA from the synthesized full length DNA template.  There are two reasons to keep the 
DNA oligos short; first when ordering custom DNA the cost of production increases 
exponentially with the length of the segment, therefore several short segments are much 
cheaper than a single long one, and second, it is extremely difficult to obtain DNA with 
high integrity when the length is > ~90 nt.  Once the full length DNA template is 
synthesized using PCR, it is possible to transcribe the desired RNA from this template.  
The transcription method works well for this particular experiment because no post-
transcriptional modifications are necessary for the unmodified PTC RNA.  An alternative 
to transcribing RNA from a DNA template is to order small segments of RNA and then 
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piece them together using ligation techniques, however this method gives inefficient 
results and is extremely difficult when dealing with long segments. 
 In this chapter I will present our experimental design for the PCR primers as well 
as the exact methods used to amplify these primers into full length DNA templates. I will 
also detail the experiments required for transcribing RNA from the previously generated 
template. 
 
Experimental Design 
 To begin the process of synthesizing the unmodified PTC RNA, we designed 
DNA primers which can be amplified via PCR.  The PTC region of 28S ribosomal RNA 
contains approximately 216 bases, so we decided to utilize a two step process for PCR to 
keep the size of the individual DNA primers as small as possible (figure 3.1).  The 
sequences of the first set of PCR primers labeled PTC1-F, for forward, and PTC1-B, for 
backward, can be found in figure 3.2.  PTC1-F is 72 nucleotides long while PTC1-B 
contains 68 nucleotides.  There is an overlapping region of 18 bases between PTC1-F and 
PTC1-B, shown in red, which allows the two primers to anneal together prior to 
elongation.  The overlapping regions of the DNA have bases which are complementary to 
each other in the standard fashion of A matching to T and C matching to G which is used  
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to form the base pairs of a double stranded helix.  This is different from the standard use 
of PCR to amplify a specific region of a DNA fragment since we are using two DNA 
primers with overlapping regions to create an entirely new custom DNA fragment.  Once 
this PCR has run, the PTC1 product must be purified from the primers and enzymes 
before the next stage of the process can begin  
 
 
 
 
 
 
 
Fig 3.1: Graphical depiction of 2-step PCR process; the colored regions match up to the 
colored sections in the sequences found in figure 3.2 
 
 
 
PTC1-F 
PTC1-B PTC2-F 
PTC2-B T7 Promoter Region 
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Fig 3.2: Sequences of PCR DNA primers; the red, blue, and green colored sections show 
overlapping regions of the primers while the purple section shows where the T7 promoter 
region is located.  
 
 
 
PTC1-F: 
5’ATAGCGACGTCGCTTTTTGATGGTTCGATGTCGGCTCTTCCTATA
TTGTGAAGCAGAATTCGCCAAGCGTTG3’ 
PTC1-B: 
5’TCACGACGGTCTAAACCCAGCTCACGTTCCCTATTAGTGGGTGA
ACAATCCAACGCTTGGCGAATTCT3’ 
PTC2-F: 
5’GGATCCAATACGACTCACTATAGGGCACAGGGATAACTGGCTT
GTGGCGGCCAAGCGTTCATAGCGACGTCGCTTTTTGA3’ 
PTC2-B: 
5’GGGCAACAGGGTCTTCTTTCCCCGCTGATTTGCATCAGTAGGGT
AAAACTAACCTGTCTCACGACGGTCTAAACCC3’ 
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 The second stage also utilizes two short DNA primers which have regions 
overlapping with the previous two primers. The sequences of these primers labeled 
PTC2-F and PTC2-B can also be seen in figure 3.2.  PTC2-F is 80 nucleotides long and 
PTC2-B is 76 nucleotides.  These primers also contain overlapping regions; shown in 
blue is the overlap region between PTC2-F and PTC1 which is 20 nucleotides long, and 
shown in green is the overlapping section between PTC2-B and PTC1 containing 18 
nucleotides.  This time the elongation stage of PCR will produce the entire DNA template 
that represents the PTC section of the 28S ribosome subunit.  There is an additional 
region on the PTC2-F primer which does not represent nucleotides present in the PTC.  
These bases are the required promoter region which T7 RNA Polymerase must bind to 
before it can start transcribing the rest of the DNA. 
 The final stage of synthesis involves transcribing the desired RNA product from 
the full length PTC DNA template.   RNA transcription is the standard machinery used in 
the cell to produce the various types of RNA used for gene expression and other tasks.  In 
this process the Polymerase enzyme reads the DNA sequence from 3’ end to 5’ end of a 
double stranded DNA template and produces a complementary sequence of RNA from 5’ 
to 3’.  In this way the RNA is transcribed from the DNA.  For our purposes in the lab the 
process is very simple and will efficiently yield our desired RNA product. 
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Synthesis of DNA Using PCR 
 The DNA primers were obtained in nanomole quantities with de-salt purity 
(sterile filtered with physiological levels of Na) from invitrogen and suspended in ddH2O 
to a final concentration of 10µM.  The first PCR reaction was run with the DNA primers 
PTC1-F and PTC1-B to optimize the conditions for obtaining the PTC1 template.  
Several variations were attempted to find the best primer concentrations.  For this PCR of 
the first primers, 10X AccuPrime PCR Buffer I (invitrogen, AccuPrime Taq DNA 
Polymerase System) was used since it was designed for smaller primer lengths less than 
200 bases.  The best PCR conditions were found to include, for a 100µL reaction: 2µL of 
PTC1-F and 2µL of PTC1-B for final concentrations of 200 nM, 10µL of 10X Buffer I 
for final concentration of 1X, 2µL Taq DNA Polymerase and 84µL ddH2O.  The amounts 
of Taq DNA Polymerase and PCR Buffer I were set as suggested in the AccuPrime 
Polymerase System protocol.  The mixture was vortexed and centrifuged briefly to 
homogenize the contents prior to loading into the PCR machine (Sprint PCR Thermal 
Cycler, Thermo Electron Corporation).  The reaction conditions were as follows: 30 
cycles of 25s at 94°C for Denaturation, then 25s at 55°C for annealing, and 15s at 68°C 
for extension.   
After PCR the DNA needs to be purified and concentrated, so a 
phenol:chloroform:isoamyl alcohol (ph:ch:iaa) extraction was done first to separate the 
protein from the DNA.  A sample protocol for this extraction is as follows: added 1X 
total reaction volume (1mL) of 25:24:1 mixture of ph:ch:iaa, vortexed until well mixed 
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and then centrifuged (Eppendorf 5810R) at 4°C, 9 krpm for 5 min.  After centrifuging the 
solution is partitioned into an aqueous top layer containing the DNA and an organic 
bottom layer containing the protein enzyme, so the top layer was pipetted off into a fresh 
tube for further purification.  Next, an extraction was done with just chloroform to rid the 
sample of any leftover phenol.  For this extraction again 1X total sample volume (950µL) 
was added of 24:1 chloroform:isoamyl alcohol mixture and then the sample was vortexed 
well and centrifuged at 4°C, 9 krpm for 5 min.  Once again the sample is partitioned into 
an aqueous top layer and an organic bottom layer and the aqueous top layer was removed.  
The sample then needed be concentrated prior to further purification.  This was done by 
centrifuging in a heated vacuum chamber or miVac (Barnstead / GeneVac, DNA-12060) 
for 1.25 hr until the sample’s volume had decreased to 75µL. 
Once the sample was free from the polymerase enzyme, the PCR product needed 
to be separated from the DNA primers; this is done via gel purification.  A 14% 
acrylamide gel was prepared as follows: 5mL 40% acrylamide, 1mL 10X TBE buffer, 
and 5.5mL ddH2O were mixed while the electrophoresis gel plates were set up with a 
single lane comb.  18µL 50% APS and 18µL TEMED were added to the acrylamide 
mixture and the gel was poured into the plates and allowed to polymerize.   The sample 
was prepared with a 6X loading dye by adding 15µL dye to 75µL DNA solution then 
added to the gel and ran at 175V for 3.5 hr.  The gel was then UV shadowed to see the 
DNA bands, and the portion of the gel containing the top DNA band was cut out and 
placed in a 10mL syringe.  In this way the gel was broken down and crushed into a 
polyprep column containing ‘crush & soak’ buffer.  This mixture was tumbled at 5°C 
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overnight, and then the liquid was emptied into a 15mL tube with more ‘crush & soak’ 
buffer and returned to the tumbler at 5°C overnight again.  The liquid from this column 
was drained into a 15mL tube and once again a chloroform extraction was performed to 
remove any enzymes.  Next, an ethanol precipitation is done to elute the DNA out of 
solution.  A sample ethanol precipitation is done by adding 10% sample volume of 3M 
NaOAc then adding 3X total volume of cold 100% ethanol, mixing well and storing in 
freezer overnight.  This mixture is then centrifuged at 4°C, 9 krpm, for 40 min to gather 
the precipitated DNA into the supernatant.  Most of the liquid is then removed from the 
tube, leaving the pellet and ~500µL of liquid which is then dried in miVac until liquid is 
gone.  The pellet of DNA is then re-suspended in ddH2O and a UV spectrophotometry 
analysis is performed to estimate the concentration of DNA.   
Utilizing the absorption properties of DNA to quantitatively determine the 
concentration of nucleic acid in a solution is crucial at several stages in the synthesis 
process.  Here we needed the concentration in order to use the correct ratio of DNA 
template to primers in the second PCR reaction.  However, with low DNA concentrations 
it can be very difficult to distinguish the peak due to the nucleic acid from the peak where 
water absorbs (<230nm), so for this particular DNA sample our best estimate was 400 
ng/µL.   
We set up the next PCR with several variations, especially of the concentration of 
the DNA template because of the uncertainty of the data.  This PCR was set up similar to 
the first one except that now we also tried both Buffer I (< 200nt) and Buffer II (for > 
200nt) as our expected product was 216nt, close to the cut-off point.  DNA primers 
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PTC2-F and PTC2-B were used in the standard concentrations called for in the 
AccuPrime protocol, while the best result for the template concentration was 0.5 µL (per 
25 µL reaction).  A 20% non-denaturing acrylamide gel was then run and stained with 
ethidium bromide viewed on a transilluminator (Fischer Scientific) to see these results 
(figure 3.3a) while a 14% non-denaturing acrylamide gel was run with the original PCR 
product and this new second PCR result (figure 3.3b). 
 
 
 
 
Figure 3.3: a) Lanes 9-14 show different variations of PCR2 reactions with lane 13 
showing the cleanest product.  b) In lane 1 is the first PCR reaction showing a band at 
~140bp, and lane 2 contains the second PCR reaction showing a band at ~215bp (dark 
arrows), while lane 3 contains a DNA ladder with the white arrow pointing at the 100bp 
reference band 
 
a) b) 
9 10 11 12 13 14 L 
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In this gel the product of the first PCR reaction (lane 1) is clearly visible just 
above the 100bp band of the DNA ladder (lane 3) while the second PCR product is 
visible in lane 2 much higher up on the gel indicating its length to be ~215bp as expected.  
With the full length unmodified PTC DNA appearing cleanly after the PCR reaction, we 
scaled up the reaction size (to 100µL) and quantity to produce a large amount of the 
DNA, then proceeded to purify and concentrate the product with phenol-chloroform 
extractions, purifying gel, and ethanol precipitations in the same manner as the previous 
reaction.  After obtaining the purified product a UV spectrophotometry scan estimated 
the DNA concentration to be 500 ng/µL or 3.5µM. 
 
Transcribing RNA from DNA Template 
 Once the DNA template had been synthesized the next step was to transcribe the 
unmodified RNA for the goal of comparing it physically to the wild-type RNA.  The 
NTPs are provided in solution for synthesis of the RNA by T7 RNA polymerase, so these 
were mixed to 100 mM concentration adapted from Promega protocols.  For CTP, 1g of 
rCTP (Sigma-Aldrich) was dissolved in ~ 5 mL ddH2O, then the pH was adjusted to 7.0 
with 10M NaOH.  The concentration of CTP in this mixture was determined by UV 
Spectrophotometry (at λmax ~ 271 nm) in a 1:104 dilution (figure 3.4).  The concentration 
was found to be 159 mM and the volume was measured at 3.8mL; the concentration was 
then adjusted to 100 mM with 18.77 mL ddH2O for a final volume of 22.57 mL.  This 
solution was sterile filtered through 0.2 µm filter into 1mL aliquots.  The same procedure 
was repeated for the other NTPs needed (UTP, GTP, and ATP).    
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Fig 3.4: The UV Spectrophotometry analysis for the CTP (red), GTP (blue), and UTP 
(green). CTP shows a peak at 270nm of 0.535A, GTP shows a peak at 252nm of 0.428A, 
and UTP shows a peak at 262nm of 0.159A. (ATP not shown) 
CTP 
GTP 
UTP 
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 The in vitro transcriptions were carried out at first using the protocols adapted 
from Cunninghan, and then modified for optimization [18,19].  The standard protocol 
was modified with the addition of polyethylene glycol (PEG) which is used to make the 
solution more viscous to simulate cellular conditions, pyrophosphatase (PPi) which 
degrades diphosphate byproducts and keeps their levels from getting too high as 
transcription occurs and inhibiting product formation, and varying concentrations of 
DNA and the NTPs [19].  A 4X transcription buffer was made according to the protocol 
adapted from Cunninghan by using final concentrations of 480 mM HEPES-KOH, 120 
mM MgCl2, 8 mM Spermidine, 160 mM DTT, and 0.04% Triton X-100 [18].  The 
conditions found to work the best so far were 200 nM concentration of the ds DNA 
template from PCR, 4 mM concentration of each of the NTPs, 0.1 units of PPi (0.5µL), 
1x transcription buffer, and 18 units (1 µL) of T7 RNA polymerase.  This product was 
run on a 10% denaturing gel (same as non-denaturing except addition of 6M urea, and the 
use of formamide 1X denaturing dye) and stained with ethidium bromide for viewing on 
a ultraviolet transilluminator (figure 3.5).  Once successful transcription results were 
seen, the reactions were scaled up to large quantities for purification.  However, the first 
several attempts at large scale transcription and purification were unsuccessful.  This was 
likely due to the DNA template degrading over the large period of time during which it 
was in constant use while the small scale transcriptions were being optimized.  Synthesis 
of a new DNA template through PCR should result in successful large scale RNA 
transcriptions. 
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Fig 3.5: A 10% denaturing acrylamide gel showing in lanes 1 and 2 a DNA ladder, in 
lane 4, an RNA transcription and in lane 10, and RNA ladder 
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CHAPTER FOUR 
SYNTHESIS OF WILD-TYPE PTC RNA 
 
 The next step after preparing modified PTC RNA constructs is to synthesize the 
natural PTC RNA as it appears in nature.  This RNA designated as wild-type will have 
the same uracil residues modified to pseudouridines as the ones found in human PTCs.  A 
difficulty immediately becomes clear with this plan, as a pseudouridylation enzyme 
normally present in vivo such as Dyskerin of the TruB family in eukaryotes and a 
targeting RNA sequence is needed to perform the modification [20].  To work around this 
requirement it would be better to insert the pseudouridylated bases into the RNA 
fragment as it is being synthesized instead of post-transcriptionally.  To this end we 
decided to order RNA fragments which we would attempt to assemble into complete PTC 
RNA using ligation techniques.  This method is difficult and fairly inefficient as 
discussed previously, however it is the best option for this experiment as far as cost-
efficiency and available laboratory equipment [21]. 
 In this chapter I will discuss the different experimental designs for the ligation 
reactions as well as the procedures used.  I will also talk about the various tests employed 
to determine the outcome of these reactions and to measure the fidelity of the products. 
 
Experimental Design 
 The first reaction design incorporated three RNA oligos with two DNA splints to 
fit between them.  The purpose of this design was to keep the RNA fragments as short as 
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possible.  Previous ligation studies have suggested that shorter fragments lead to more 
efficient ligation as longer, more structured, fragments have the least product yield [21].  
The PTC section of the 28S ribosomal RNA is one of the most highly structured and 
stable RNAs in the body so, to facilitate the formation of a hybridized RNA:DNA:RNA 
pre-ligation complex, the length of the oligos and the ligation sites have been carefully 
determined [3]. 
The sequences of the PTC-1, PTC-2, and PTC-3 RNA oligos along with DNA 
splint-1, DNA splint-2, and a graphical view of the ligation sites in relation to the 
secondary structure of the PTC can be seen in figures 4.1 and 4.2 respectively.  The PTC 
is joined to the rest of the 28S ribosomal RNA by two base-paired helixes; when 
designing our RNA oligos we decided to leave one of these joints open and close the 
other off with a tetra loop. In the graphical overview of the PTC, the bases added in to 
create the tetra loop closing off one end and to facilitate base-pairing at the open end are 
marked in red (figure 4.2).  The PTC-1 construct contains 66 bases and the PTC-2 
construct contains 80 bases.  The splint that joins these two pieces of the PTC, DNA 
splint-1, is 42 bases long with 22 complementary bases overlapping PTC-1 and 20 bases 
overlapping PTC-2.  PTC-2 is joined with PTC-3 which has 73 nucleotides by DNA 
splint-2 which is 42 bases long and overlaps PTC-2 with 25 complementary bases and 
PTC-3 with 17 bases to form the hybridized ligation complex.  The length of the DNA 
splints has a moderate effect on the efficiency of the ligation reaction with an overlapping 
length of at least 15 complementary bases on each side having the optimum results [22].   
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Fig 4.1:  Sequences of PTC RNA pieces and DNA splints.  The colored regions show the 
overlapping portions of the splints which are complementary to the RNA. (Ψ designates 
pseudouridine) 
 
PTC-1 
5’GGGCACAGGGAUAACUGGCUUGUGGCGGCCAAGCGUΨCAΨAGCGAC
GΨCGCUUUUUGAΨCCUUCGA-3’ 
PTC-2 
5’PUGUCGGCΨCUUCCUAUCAUUGΨGAAGCAGAAUUCGCCAAGCGUUG
GAUUGΨUCACCCACUAAUAGGGAACGΨGAGCUGGG-3’ 
PTC-3 
5’PUΨUAGACCGUCGUGAGACAGGUΨAGUUUUACCCUACUGAUGCAAA
UCAGCGGGGAAAGAAGACCCUGUUGCCC-3’ 
DNA Splint-1 
5’-AATGATAGGAAGAGCCGACATCGAAGGATCAAAAAGCGACGT-3’ 
DNA Splint-2 
5’-TCTCACGACGGTCTAAACCCAGCTCACGTTCCCTATTAGTGG-3’ 
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Fig 4.2: Graphical depiction of first ligation design with PTC-1 bracketed off in blue, 
PTC-2 bracketed off in red, and PTC-3 bracketed off in Green.  The red bases indicate 
custom bases we inserted which are not in the PTC [2] 
C 
A 
G 
G 
G 
C 
C 
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PTC-3 PTC-1 
PTC-2 
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We chose to use commercially available T4 DNA ligase from Promega as our 
ligation enzyme for its purity and standardized availability.  Since there are two different 
ligation sites with this design, two different options were available for the ligation 
reaction.  We tested the viability both of ligating PTC-1 and PTC-2 together then ligating 
the remaining RNA construct PTC-3 to the two pieces already joined and also of ligating 
all three oligos together in one ligation reaction. 
To ensure that we had the best possible chance of synthesizing this piece of 
ribosomal RNA, we also designed a second ligation plan using different lengths of RNA 
and having different ligation sites.  The PTC RNA forms many secondary structures such 
as tetra-loops, alpha-helixes, and hairpins; so this plan will break the RNA up in a 
different location than the first one in an effort to reduce the secondary structure 
formation during the annealing step of the ligation reaction [2]. 
There are two RNA oligos to be joined this time with one DNA splint to fit 
between them (figure 4.3).  ΨPTC-1 is 89 nucleotides long while ΨPTC-2 contains 88 
nucleotides and DNA splint-Ψ1 is 36 bases long (figure 4.4).  This splint design has 18 
complementary bases overlapping on each RNA construct to ensure base pairing with the 
RNA is favorable.  The ligation site was chosen to be in the loop at then of a helix for this 
design instead of in a straight non base-pairing section.  This will possibly break up the 
secondary structure that the RNA normally forms and allow for it to be more easily 
denatured and bound to the DNA splint.  In an effort to still keep the RNA oligos to be 
ligated as short as possible, the looped off connecting segment has been shortened 
significantly in this design.  The bases shown in red represent the modified sections of the 
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PTC RNA where the connecting loop was shortened and the base-pairing region was also 
shortened but made more stable by the use of G—C base pairs with their triplet of 
hydrogen bonds.  This design results in a total of 177 nucleotides as compared to the 219 
nucleotides of the three piece design; however, these bases were cut in regions that 
simply connect the PTC to the rest of the RNA and are therefore not thought to play a 
part in the PTC’s catalytic core. 
As a control for the ligation and to test various reaction conditions, two short 
RNA oligos (10nt) were ordered along with a DNA splint (20 nt) to join them.  These 
constructs were designed to have little secondary structure in order to represent an ideal 
ligation situation.  The sequences of test ligation RNA acceptor (TLRNA-A), test ligation 
RNA donor (TLRNA-D), and test ligation DNA splint (TLDNA-S) are also shown in 
figure 4.4. 
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Fig 4.3: Graphical representation of second ligation design with ΨPTC-1 bracketed off in 
blue and ΨPTC-2 bracketed off in green.  The red bases indicate custom bases we 
inserted which are not in the PTC [2] 
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Fig 4.4: Sequences of PTC RNA pieces and the DNA splint as well as the test ligation 
RNA and DNA splint.  The colored regions show the overlapping portions of the splint 
which are complementary to the RNA.  (Ψ designates pseudouridine) 
 
 
TLDNA-S 
5’-TCCGAACTTGTGGCTTCATC-3’ 
TLRNA-D 
5’-PCAAGUUCGGA-3’ 
TLRNA-A 
5’-GAUGAAGCCA-3’ 
DNA Splint-Ψ1 
5’-CCAACGCTTGGCGAATTCTGCTTCACAATGATAGGA-3’ 
ΨPTC-2 
5’PGAAUUCGCCAAGCGUUGGAUUGΨUCACCCACUAAUAGGGAACGΨGA
GCUGGGUΨUAGACGUGAGUΨAGUUUCGUGAGAGAAGACCCGG-3’ 
ΨPTC-1 
5’CCGGGAUAACUGGCUUGUGGCGGCCAAGCGUΨCAΨAGCGACGΨCGCU
UUUUGAΨCCUUCGAUGUCGGCΨCUUCCUAUCAUUGΨGAAGCA-3’ 
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Ligation of PTC RNA 
 The PTC RNA constructs were obtained from Dharmacon RNA Technologies in 
a 2’-ACE protected state and so needed to be deprotected upon arrival.  The deprotection 
protocol provided by Dharmacon was followed as follows: the tubes were briefly 
centrifuged, then 400 µL of 2’-Deprotection buffer (100 mM acetic acid pH adjusted to 
3.8 with TEMED) was added to the RNA and mixed until the RNA was dissolved into 
solution, the tube was then incubated at 60 °C for 30 min and speedvacced until dry.  
Based on the number of moles of each construct provided, the amount of ddH2O that 
needed to be added to achieve a final concentration of 200 µM was calculated.  The DNA 
splints were obtained from Invitrogen Custom Primers and were suspended in ddH2O to a 
final concentration of 500 µM.  The PTC RNAs were then diluted into aliquots of 25 µM, 
to avoid contamination of the main stock, while the DNA splints were diluted into 
aliquots of 20 µM. 
 The first DNA-splinted ligation reaction was then set up according to protocols 
adapted from those found to work best for small highly structured RNAs by Kurschat et 
al. and for RNAs for crystallization [21,22].  Kurschat et al. studied the effects of 
temperature and splint length of the ligation product yield [22].  When ligating RNAs on 
the order of ~35 nt which form a significant number of secondary structures, they found 
that lower temperature worked best with the amount of full-length product increasing 
from 2% to 12% as the reaction incubation temperature decreased from 30 °C to 15 °C.  
However, Ke and Doudna found that for their ligation of a 62-mer and a 13-mer that a 
temperature of 30 °C produced better results than lower temperatures of 16 and 4 °C [21].  
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The two papers do agree on splint length though, both suggesting that a longer 
complementary splint sequence overlapping each of the donor and acceptor RNAs by at 
least 15 bases produces the best results.  In addition, Ke and Doudna found that the 
formation of the RNA:DNA:RNA ligation complex was strongly dependant on the ratio 
of the different components of the reaction with a optimum ratio of 2:1.5:1 (RNA 
acceptor : DNA splint : RNA donor) [21].  They also determined that the incubation time 
which yielded the highest level of ligation complexes was 5-7 hr.   
Taking all of these previous findings into consideration, three initial reactions 
were tried with the following parameters: A) 2 µM concentration of PTC1, 1 µM of 
PTC2, and 3 µM of splint-1, B) 2 µM PTC2, 1 µM PTC3, 3 µM splint-2, and C) 2 µM 
PTC1, 3 µM PTC2, 1 µM PTC3, 3 µM splint-1, and 3 µM splint-2 along with 1X ligation 
buffer (50 mM Tris pH 7.5, 10 mM MgCl2, and 10 mM DTT sterile filtered) and 10 units 
(0.5 µL) T4 DNA Ligase (Promega).  The tubes were filled to final volume (10 µL) with 
ddH2O and these were all mixed and centrifuged prior to incubation at 25.5 °C for 6 hr.  
A 10% denaturing acrylamide gel was ran with the ligation reactions, the individual PTC 
RNAs and an RNA ladder to view initial results (figure 4.5).  The different reactions here 
were run to test the viability of ligating just the first and second RNAs together, just the 
second and third RNAs, or all three RNAs at the same time.  The gel showed that the 
initial attempts were not successful as the reaction lanes only showed strong bands 
around the same location on the gel as the PTC RNAs ran individually.   
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Figure 4.5: 10% denaturing acrylamide gel showing results of initial ligation trials.  RNA 
ladder in lane labeled RL with arrow pointing to 100 nt band; lanes 5 & 6 contain the 
dual ligation reaction; lanes 3 & 4 contain the second ligation (PTC2 & PTC3); lanes 1 & 
2 contain the first ligation (PTC1 & PTC2); lanes P1, P2, and P3 contain the individual 
RNAs PTC1, PTC2, and PTC3 respectively 
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To begin trouble shooting of the reaction a UV spectrophotometry scan was done 
of each nucleic acid construct to ensure that concentrations were as calculated.  The 
results of the UV scan indicated that the concentrations were slightly off from those 
calculated with PTC1 at ~60 µM, PTC2 and PTC3 at ~20 µM, and the DNA splints at 
~40 µM.  With these new concentrations the ligation reaction was recalculated with an 
additional change to the protocol of adding an annealing step prior to incubation.  This 
was accomplished by adding the ddH2O, RNA, and DNA to the tube, then heating it to 
90 °C for 2 min and cooling to 25 °C before adding the buffer and ligase then incubating.  
A 10% denaturing acrylamide gel was again used to view this ligation reaction, but the 
results proved to be the same.  After this several more variations were attempted 
including increased concentrations, varying component ratios, and low and high reaction 
temperatures without any improvements to the result. 
At this stage the test ligation RNAs were used to ensure that the ligation 
conditions could produce a full length product if the RNA was of ideal length and 
structure.  The DNA was suspended in ddH2O to a concentration of ~500 µM then a UV 
scan was run which estimated the concentration at 586 µM.  The DNA was then diluted 
into an aliquot of ~100 µM concentration.  The RNA was deprotected using the same 
protocol as above and suspended in ddH2O for a concentration of 200 µM.  A UV 
absorbance scan then showed the actual concentrations to be approximately 260 µM for 
TLRNA-A and 210 µM for TLRNA-D.  A ligation reaction was then run using these 
RNA and DNA oligos and the latest protocol that had been used for the 3-part PTC 
ligation (30 µM RNA acceptor, 15 µM RNA donor, 45 µM DNA splint, 90 °C annealing 
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stage for 2 min, cool on ice for 5 min, and 20 °C incubation stage with buffer and T4 
Ligase).  After optimizing gel conditions for these short nucleic acid strands a successful 
result was clearly seen on the gel with a distinct double band in the ligation lanes (stained 
with Nuclistain; gel not pictured).  As the conditions for the ligation worked quite well 
for the ideal oligos, but not for the PTC RNAs, further changes were necessary. 
The second ligation design, with two PTC RNAs instead of three, was now tested 
to see if it could be annealed together with better results.  First, as usual, the RNAs were 
deprotected and suspended in ddH2O to a concentration of 150 µM and then UV 
absorbance scans were run to determine an experimental concentration (figure 4.6).  
ΨPTC1 had a concentration of ~148 µM while ΨPTC2 had a concentration of ~135 µM.  
The DNA splint Ψ1 was also suspended in ddH2O and had its UV absorbance scanned to 
indicate a concentration of ~213 µM. 
The first ligation reaction with the new oligos was set up with the protocol that 
worked best for the test ligation RNAs: 30 µM ΨPTC1, 15 µM ΨPTC2, 45 µM splint Ψ1, 
with 20 °C incubation.  At this point the gels were coming out with long streaks in the 
lanes and without clear bands, so while trying different ligation conditions the gel 
imaging process was also being optimized to get a clearer picture of the reaction results 
(figure 4.7).   
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Figure 4.6:  A) absorbance scan of ΨPTC1 with a peak at 259 nm of 0.114A, B) 
absorbance scan of ΨPTC2 with a peak at 257 nm of 0.104A 
 
 
 
 
 
 
Figure 4.7:  Lane 1 contains an RNA ladder; lanes 2 and 3 show material above the 100 
nt band of the ladder, while lanes 4 and 5 show a large amount of material corresponding 
to ~90 nt according to the RNA ladder and a ‘shadowed’ band well below 100 nt 
A) B) 
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The success of this reaction is ambiguous, as there is a distinct band around 90 nt 
which is likely the unligated ΨPTC RNA, however in the control bands on this gel 
(containing the nucleic acid oligos but not T4 DNA ligase), there is a large amount of 
material well above the 100 and even 200 nt bands.  Also, in the ligation lanes there is a 
‘shadowed’ band where there is a large quantity of material which may correspond to a 
faster-migrating ligated product [23]. However, this band appears where the DNA splint 
should run, raising the question as to whether PTC1 and PTC2 are actually ligated. 
Interestingly, this band does not appear in the control lanes. 
Further PTC ligations were done in an attempt to get clear and consistent results; 
however, it was not very reproducible, despite the many different reactions run.  A 
possible reason that these results were not repeatable is that the reaction conditions may 
need to be exact; therefore a slight change from one reaction to another in temperature or 
amount of ligase could result in the ligation becoming unfavorable.  While these 
conditions were controlled very carefully, small changes are possible.  Another result was 
promising though it also could not be repeated, so it was not able to be determined 
whether a full length ligated product had been created (figure 4.8).  In this gel there are 3 
distinct bands with more material at the top yet to enter the gel.  The bottom band is again 
suspected to be the DNA splint; however the middle and top band division is new and it 
is unknown what they represent as unfortunately the RNA ladder was not run on this gel, 
so approximate lengths cannot be determined.  The spacing between the two bands is 
fairly large, so it is unlikely that they represent the two unligated oligos ΨPTC1 and 
ΨPTC2 which only differ in length by one base.  This seems to have been the most 
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positive result for a ligation so far and many attempts to repeat the reaction with these 
conditions yielded only unclear bands and ‘streaky’ lanes as was seen in figure 4.7.  This 
inconsistency only reinforces the theory established earlier that ligations are extremely 
sensitive reactions which only occur under precisely the right conditions. 
 
 
 
 
 
Figure 4.8:  Three distinct bands in this gel are shown by white arrows 
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Once gel conditions were optimized for better viewing of results (6% denaturing 
acrylamide gel, 160V, 1.25hr) a control gel was run against a ligation product with the 
conditions that produced the best results above.  This gel contained the individual ΨPTC 
RNA’s and the DNA splin-Ψ1 (figure 4.9).  It clearly shows that the bottom band being 
produced is the DNA splint in the reaction, while a single band up top corresponds to 
about the same position as the RNA oligos in the reaction; there is no double band 
arrangement as seen before to indicate ligated full-length product. 
 
 
 
Figure 4.9:  Lane Ψ1 shows the ΨPTC1 RNA, lane Ψ2 shows the ΨPTC2 RNA, lane L 
shows the RNA ladder with an arrow pointing to the 100 nt bottom band, lane PTC-12 
shows the ligation reaction, and lane “Splint” shows the DNA splint-Ψ1.  The top band 
marked with an arrow corresponds to unligated RNA in the ligation reaction; while the 
bottom band marked with an arrow shows that the bottom band in the ligation reaction is 
the same as DNA splint-Ψ1 
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These reactions show that there is much inconsistency when trying to ligate RNA 
as large and highly structured as that of the PTC in the ribosome.  There are occasional 
results which indicate the possibility of success, but overall they are few and far between 
the many results which show only the original constructs.  The many different variations 
of the ‘standard’ ligation reaction which were employed may not be exhaustive, but are 
nearly so as every parameter has been varied in multiple ways.  The comparison between 
the ease with which the test RNAs were ligated and the vast number of unsuccessful 
attempts at ligating the PTC RNA, despite having two different designs to work with, 
simply underlines the value of this piece of RNA and the importance its structure must 
have to be so unwavering. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
In review, the experimental design and procedure worked quite well for 
synthesizing a full length DNA template representing the complement of the unmodified 
PTC RNA.  Both PCRs were successful and had large scale purified results.  The next 
phase of performing in vitro transcriptions of PTC RNA from this template worked to 
some extent.  The transcriptions produced RNA on an analytical scale as was seen in 
many acrylamide gels that were run to view these results.  However, repeating this 
reaction on a large scale for purification and biophysical tests is still an ongoing task. 
The synthesis of the wild-type PTC RNA oligonucleotides saw somewhat 
ambiguous results.  The conditions for the ligation reaction were tested by the design of 
an ideal ligation complex and produced excellent results.  However, when these 
conditions were applied to the two and three piece PTC ligation designs, the results were 
much less clear.  These two reactions were designed to test different ways of forming a 
ligation complex; one way was to avoid RNA secondary structure at the ligation site, and 
the second way tried to break up the RNA’s secondary structure by placing the ligation 
site in the middle of a loop.  The three piece ligation design hasn’t yet seen any possible 
successes, but the two piece design produced several gels that were successful at best and 
ambiguous at worst.  Without consistently being able to repeat these questionable results, 
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it is extremely hard to gauge the success of the attempts.  There is strong evidence 
though, that a ligation product is being produced some of the time. 
 
Future Work 
The work presented here has been but a preliminary study in this ongoing project 
and there are certainly many things left to be done.  The in vitro transcriptions of the 
unmodified PTC RNA still need to be optimized for large scale reactions.  This step in 
the process is close to completion and needs but a little more work.  As for the ligations 
of the wild-type PTC RNA, the current designs have only produced inconsistent and 
unclear data.  For this part of the project a redesign may be in order and there are a couple 
of promising directions it could go in.  First, according to Baum and Silverman, 
designing a ligation reaction is extremely difficult due to the unpredictability of which 
ligation site will yield a successful product [24].  So even though two different designs 
have been tried, with a total of three different ligation sites, there are certainly many more 
choices available and they must be tested by experiment to determine if they are good 
ligation sites.  Secondly, this research focused on DNA-splinted ligation with T4 DNA 
ligase; however, a recent method which is gaining favor with RNA researchers involves 
the use of an RNA ligase instead [14,25].  There are several options when using RNA 
ligase including RNA or DNA splinted option, a Y-ligation, or a single stranded ligation.  
An added benefit of the RNA ligase method is that it can work by sealing a nick in a loop 
structure.  Given the many loops in the PTC RNA this could be an ideal method.   
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With this work done and the wild-type and unmodified PTC RNAs in hand, 
several biophysical characterizations can be done to test our hypothesis that the 
pseudouridines collectively play a biologically significant structural role within the PTC.  
UV denaturation tests will be done by measuring the absorbance of the samples at λmax 
while slowly varying the temperature from physiological to denaturing.  This will give 
data about the temperature at which each molecule is denatured or Tm; this can then be 
used to determine an equilibrium constant for the molecule which will yield 
thermodynamic properties such as heat of enthalpy and heat of entropy when used in 
Van’t Hoff’s equation ( ln (K) = - ∆H/RT + ∆S/R ). 
Circular Dichroism will yield a spectrum for each sample which will reveal which 
known structures are present and how strongly they are formed.  This data can be 
compared between the two samples for an idea of whether they are completely different 
or if the pseudouridines confer any enhancements to the CD’s structural signal. 
Small angle x-ray scattering (SAXS) is a third technique which will be used to 
gather data in support of our hypothesis.  This tool is especially useful as it gives global 
conformation and radius of gyration data on the samples.  When comparing the two 
RNAs with this method, it will be clear whether one has a more compact, tightly 
structured conformation, a completely different conformation, or the same conformation 
as the other sample.  In addition, given the ability of SAXS to collect data on a sample in 
solution, Mg2+ titrations can be performed which will allow the structure of the RNA to 
be observed from an unfolded state to folded state.  When comparing data of this sort 
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between the unmodified and wild-type PTC RNAs it will be evident whether 
pseudouridines play a part in the folding process of the RNA. 
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